Last reviewed · How we verify
Nirogacestat and Famotidine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Nirogacestat and Famotidine (Nirogacestat and Famotidine) — SpringWorks Therapeutics, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Nirogacestat and Famotidine TARGET | Nirogacestat and Famotidine | SpringWorks Therapeutics, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Nirogacestat and Famotidine CI watch — RSS
- Nirogacestat and Famotidine CI watch — Atom
- Nirogacestat and Famotidine CI watch — JSON
- Nirogacestat and Famotidine alone — RSS
Cite this brief
Drug Landscape (2026). Nirogacestat and Famotidine — Competitive Intelligence Brief. https://druglandscape.com/ci/nirogacestat-and-famotidine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab